Form 8-K - Current report:
SEC Accession No. 0001193125-16-450055
Filing Date
2016-02-04
Accepted
2016-02-04 09:02:37
Documents
2
Period of Report
2016-02-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d125062d8k.htm 8-K 15199
2 EX-10.1 d125062dex101.htm EX-10.1 20489
  Complete submission text file 0001193125-16-450055.txt   36839
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34186 | Film No.: 161386954
SIC: 2834 Pharmaceutical Preparations